AstraZeneca Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	223,029	213,845	162,287	164,292	173,826	134,436
Market Cap Growth	19.23%	31.77%	-1.22%	-5.49%	29.30%	39.84%
Enterprise Value	240,888	232,118	182,260	184,338	197,853	154,735
Last Close Price	143.80	136.48	101.41	100.48	104.16	78.72
PE Ratio	29.59	28.15	28.88	35.14	63.70	1625.31
Forward PE	18.42	18.34	14.36	17.08	18.65	18.61
PS Ratio	5.11	4.90	3.76	4.57	4.72	4.87
PB Ratio	6.16	5.91	4.97	5.34	5.65	4.63
P/FCF Ratio	25.51	24.46	20.45	23.29	24.03	37.36
P/OCF Ratio	20.60	19.75	17.13	20.23	21.35	30.53
PEG Ratio	1.43	1.54	1.17	1.47	1.29	0.95
EV/Sales Ratio	5.52	5.32	4.22	5.13	5.38	5.60
EV/EBITDA Ratio	16.48	16.20	12.99	16.45	17.35	31.27
EV/EBIT Ratio	22.70	21.86	17.65	24.21	27.05	72.32
EV/FCF Ratio	27.56	26.55	22.96	26.14	27.35	43.01
Debt / Equity Ratio	0.61	0.61	0.75	0.76	0.84	0.85
Debt / EBITDA Ratio	1.51	1.51	1.70	2.04	2.23	4.81
Debt / FCF Ratio	2.53	2.53	3.07	3.30	3.57	6.85
Net Debt / Equity Ratio	0.49	0.49	0.61	0.61	0.67	0.69
Net Debt / EBITDA Ratio	1.24	1.24	1.42	1.67	1.81	4.02
Net Debt / FCF Ratio	2.04	2.04	2.51	2.65	2.86	5.54
Asset Turnover	0.54	0.54	0.53	0.46	0.44	0.44
Inventory Turnover	1.81	1.81	1.80	1.59	1.26	1.85
Quick Ratio	0.65	0.65	0.67	0.58	0.62	0.67
Current Ratio	0.94	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	22.84%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	8.19%	8.19%	7.88%	6.13%	5.46%	2.10%
Return on Invested Capital (ROIC)	16.48%	17.03%	16.27%	13.42%	13.75%	6.00%
Return on Capital Employed (ROCE)	17.10%	17.10%	17.00%	13.70%	12.60%	3.50%
Earnings Yield	3.41%	3.55%	3.46%	2.85%	1.57%	0.06%
FCF Yield	3.92%	4.09%	4.89%	4.29%	4.16%	2.68%
Dividend Yield	1.64%	1.74%	2.44%	2.27%	2.31%	2.69%
Payout Ratio	47.39%	47.39%	65.47%	75.42%	132.72%	3442.86%
Buyback Yield / Dilution	0.06%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	1.71%	1.81%	2.38%	2.14%	-7.01%	-5.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.